Company profile

Ticker
ABBV
Exchange
CEO
Richard A. Gonzalez
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
320375147

ABBV stock data

(
)

Calendar

5 Aug 19
19 Aug 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 8.26B 7.83B 8.31B 8.24B
Net income 741M 2.46B -1.83B 2.75B
Diluted EPS 0.49 1.65 -1.23 1.81
Net profit margin 8.98% 31.37% -21.99% 33.35%
Operating income 3.4B 3.01B -2.44B 3.16B
Net change in cash 275M -2.39B -726M 4.47B
Cash on hand 5.17B 4.9B 7.29B 8.02B
Cost of revenue 1.82B 1.69B 2.02B 1.84B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 32.75B 28.22B 25.64B 22.86B
Net income 5.69B 5.31B 5.95B 5.14B
Diluted EPS 3.66 3.3 3.63 3.13
Net profit margin 17.36% 18.82% 23.22% 22.50%
Operating income 6.38B 9.55B 9.34B 7.54B
Net change in cash -2.01B 4.2B -3.3B 51M
Cash on hand 7.29B 9.3B 5.1B 8.4B
Cost of revenue 7.72B 7.04B 5.83B 4.5B

Financial data from AbbVie earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: abnormality, acetate, adenosine, Allergan, amended, Amendment, amplification, antibody, Appendix, Bank, BBB, biologic, biomarker, bleeding, branded, breast, bridge, CANOVA, carboplatin, CFR, commonly, consummation, contemplated, criteria, daily, delay, depatuxizumab, device, drawn, duly, EGFR, epidermal, event, exhibit, eye, formatted, Foundation, furnished, futility, germline, glioblastoma, GOG, halted, heavy, hereto, herewith, impose, Inline, Investor, issuer, iXBRL, jeopardize, JPMorgan, jurisdictional, lack, Language, leader, lifted, mafodotin, menstrual, MM, Moody, Morgan, negative, negatively, notch, outlined, outlook, ovarian, paclitaxel, palsy, PARP, pattern, poly, polymerase, progressive, prolonged, protocol, radiation, recommended, regenerative, Section, showed, Stanley, SubsidiariesCondensed, supranuclear, surgical, survival, temozolomide, thereto, thereunto, timeframe, timeline, tranche, translocation, undersigned, VELIA, veliparib
Removed: affiliated, appellate, breakthrough, Chancery, designation, eleven, fixed, Fournier, improvement, Industrie, led, Louisiana, principle, proceeding, reached, reinstatement, Sante, sNDA, sought, transfer, TriCor, unspecified